Abstract
Acromegaly is accompanied by increased cardiovascular mortality and a cluster of proatherogenic risk factors. In the general population, ischaemic heart disease (IHD) is associated with elevated levels of inflammatory markers. The acute phase reactant (APR) C-reactive protein (CRP) has been reported to be reduced in acromegaly and increase after treatment, suggesting that excess of GH/IGF-I could have anti-inflammatory effects. This is in accordance with results obtained in patients with growth hormone deficiency (GHD), where increased levels of CRP have been reported.
Original language | English |
---|---|
Journal | Clinical Endocrinology |
Volume | 67 |
Issue number | 6 |
Pages (from-to) | 909-16 |
Number of pages | 8 |
ISSN | 0300-0664 |
DOIs | |
Publication status | Published - Dec 2007 |
Keywords
- Acromegaly
- Adipokines
- Adolescent
- Adult
- C-Reactive Protein
- Case-Control Studies
- Dwarfism, Pituitary
- Female
- Human Growth Hormone
- Humans
- Insulin-Like Growth Factor I
- Interleukin-6
- Lectins
- Male
- Middle Aged
- Young Adult